Cardiovascular Systems Inc
F:R7Y1
Cardiovascular Systems Inc?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
N/A
N/A
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
What unique competitive advantages
does Cardiovascular Systems Inc hold over its rivals?
What risks and challenges
does Cardiovascular Systems Inc face in the near future?
Provide an overview of the primary business activities
of Cardiovascular Systems Inc.
Show me price targets
for Cardiovascular Systems Inc made by professional analysts.
Provide an overview of the primary business activities
of Cardiovascular Systems Inc.
What unique competitive advantages
does Cardiovascular Systems Inc hold over its rivals?
What risks and challenges
does Cardiovascular Systems Inc face in the near future?
Show all valuation multiples
for Cardiovascular Systems Inc.
Provide P/S
for Cardiovascular Systems Inc.
Provide P/E
for Cardiovascular Systems Inc.
Provide P/OCF
for Cardiovascular Systems Inc.
Provide P/FCFE
for Cardiovascular Systems Inc.
Provide P/B
for Cardiovascular Systems Inc.
Provide EV/S
for Cardiovascular Systems Inc.
Provide EV/GP
for Cardiovascular Systems Inc.
Provide EV/EBITDA
for Cardiovascular Systems Inc.
Provide EV/EBIT
for Cardiovascular Systems Inc.
Provide EV/OCF
for Cardiovascular Systems Inc.
Provide EV/FCFF
for Cardiovascular Systems Inc.
Provide EV/IC
for Cardiovascular Systems Inc.
Show me price targets
for Cardiovascular Systems Inc made by professional analysts.
What are the Revenue projections
for Cardiovascular Systems Inc?
How accurate were the past Revenue estimates
for Cardiovascular Systems Inc?
What are the Net Income projections
for Cardiovascular Systems Inc?
How accurate were the past Net Income estimates
for Cardiovascular Systems Inc?
What are the EPS projections
for Cardiovascular Systems Inc?
How accurate were the past EPS estimates
for Cardiovascular Systems Inc?
What are the EBIT projections
for Cardiovascular Systems Inc?
How accurate were the past EBIT estimates
for Cardiovascular Systems Inc?
Compare the revenue forecasts
for Cardiovascular Systems Inc with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Cardiovascular Systems Inc and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Cardiovascular Systems Inc against its competitors.
Analyze the profit margins
(gross, operating, and net) of Cardiovascular Systems Inc compared to its peers.
Compare the P/E ratios
of Cardiovascular Systems Inc against its peers.
Discuss the investment returns and shareholder value creation
comparing Cardiovascular Systems Inc with its peers.
Analyze the financial leverage
of Cardiovascular Systems Inc compared to its main competitors.
Show all profitability ratios
for Cardiovascular Systems Inc.
Provide ROE
for Cardiovascular Systems Inc.
Provide ROA
for Cardiovascular Systems Inc.
Provide ROIC
for Cardiovascular Systems Inc.
Provide ROCE
for Cardiovascular Systems Inc.
Provide Gross Margin
for Cardiovascular Systems Inc.
Provide Operating Margin
for Cardiovascular Systems Inc.
Provide Net Margin
for Cardiovascular Systems Inc.
Provide FCF Margin
for Cardiovascular Systems Inc.
Show all solvency ratios
for Cardiovascular Systems Inc.
Provide D/E Ratio
for Cardiovascular Systems Inc.
Provide D/A Ratio
for Cardiovascular Systems Inc.
Provide Interest Coverage Ratio
for Cardiovascular Systems Inc.
Provide Altman Z-Score Ratio
for Cardiovascular Systems Inc.
Provide Quick Ratio
for Cardiovascular Systems Inc.
Provide Current Ratio
for Cardiovascular Systems Inc.
Provide Cash Ratio
for Cardiovascular Systems Inc.
What is the historical Revenue growth
over the last 5 years for Cardiovascular Systems Inc?
What is the historical Net Income growth
over the last 5 years for Cardiovascular Systems Inc?
What is the current Free Cash Flow
of Cardiovascular Systems Inc?
Discuss the annual earnings per share (EPS)
trend over the past five years for Cardiovascular Systems Inc.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
US |
C
|
Cardiovascular Systems Inc
F:R7Y1
|
755.4m EUR | -23.1 | |
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
220.2B USD | 20.8 |
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
177.5B USD | 56.1 |
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
157.1B USD | 36.4 |
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
154.2B USD | 26.6 |
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
119.1B USD | 14.2 |
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
53.8B EUR | 14.4 |
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
53.1B USD | 13.8 |
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
47.1B USD | 25.9 |
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.8B USD | 36.2 |
|
US |
![]() |
Resmed Inc
NYSE:RMD
|
40.5B USD | 22 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
US |
C
|
Cardiovascular Systems Inc
F:R7Y1
|
Average EV/EBITDA:
26.6
|
N/A | N/A | |
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
20.8
|
13%
|
1.6 |
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
56.1
|
24%
|
2.3 |
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
36.4
|
21%
|
1.7 |
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
26.6
|
12%
|
2.2 |
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
14.2
|
7%
|
2 |
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
14.4
|
14%
|
1 |
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
13.8
|
11%
|
1.3 |
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
25.9
|
12%
|
2.2 |
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
36.2
|
12%
|
3 |
|
US |
![]() |
Resmed Inc
NYSE:RMD
|
22
|
12%
|
1.8 |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.